Risk factors for mortality in patients receiving extracorporeal membrane oxygenation
- PMID: 39212239
- PMCID: PMC11370676
- DOI: 10.1080/0886022X.2024.2395450
Risk factors for mortality in patients receiving extracorporeal membrane oxygenation
Abstract
Objective: Patients on extracorporeal membrane oxygenation (ECMO) are often complex and have a high mortality rate. Currently, risk assessment and treatment decisions for patients receiving ECMO are controversial. Therefore, we sought to identify risk factors for mortality in patients receiving ECMO and provide a reference for patient management.
Methods: We retrospectively analyzed the clinical data of 199 patients who received ECMO support from December 2013 to April 2023. Univariate and multivariable logistic regression analyses were used to identify risk factors. The cutoff value was determined by receiver operating characteristic (ROC) curve analysis.
Results: A total of 199 patients were selected for this study, and the mortality rate was 76.38%. More than half of the patients underwent surgery during hospitalization. Multivariable logistic regression analysis revealed that continuous renal replacement therapy (CRRT) implantation (OR = 2.994; 95% CI, 1.405-6.167; p = 0.004) and age (OR = 1.021; 95% CI, 1.002-1.040; p = 0.032) were the independent risk factors for mortality. In the ROC curve analysis, age had the best predictive effect (AUC 0.646, 95% CI 0.559-0.732, p = 0.003) for death when the cutoff value was 48.5 years. Furthermore, in patients receiving combined CRRT and ECMO, lack of congenital heart disease and previous surgical history were the independent risk factors for mortality.
Conclusions: CRRT implantation and age were independent risk factors for patients with ECMO implantation in a predominantly surgical cohort. In patients receiving a combination of CRRT and ECMO, lack of congenital heart disease and previous surgical history were independent risk factors for mortality.
Keywords: Extracorporeal membrane oxygenation; acute renal injury; continuous renal replacement therapy; mortality; risk factors.
Conflict of interest statement
No potential conflict of interest was reported by the authors.
Figures


Similar articles
-
Risk factors for mortality in surgical patients on combined continuous renal replacement therapy and extracorporeal membrane oxygenation: single-center retrospective study.Ren Fail. 2023;45(2):2282019. doi: 10.1080/0886022X.2023.2282019. Epub 2023 Nov 20. Ren Fail. 2023. PMID: 37982218 Free PMC article.
-
Risk factors associated with hospital mortality in non-surgical patients receiving extracorporeal membrane oxygenation and continuous renal replacement treatment: a retrospective analysis.Ren Fail. 2024 Dec;46(2):2398711. doi: 10.1080/0886022X.2024.2398711. Epub 2024 Sep 5. Ren Fail. 2024. PMID: 39238266 Free PMC article.
-
Risk factors for mortality in patients with sepsis on extracorporeal membrane oxygenation and/or continuous renal replacement therapy: a retrospective cohort study based on MIMIC-IV database.Ren Fail. 2024 Dec;46(2):2436106. doi: 10.1080/0886022X.2024.2436106. Epub 2024 Dec 4. Ren Fail. 2024. PMID: 39632252 Free PMC article.
-
Continuous renal replacement therapy in patients treated with extracorporeal membrane oxygenation.Semin Dial. 2021 Nov;34(6):537-549. doi: 10.1111/sdi.12965. Epub 2021 Mar 25. Semin Dial. 2021. PMID: 33765346 Free PMC article. Review.
-
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1. Crit Care. 2021. PMID: 34127027 Free PMC article.
Cited by
-
Clinical effects of combination therapy with continuous renal replacement therapy and continuous intravenous sodium infusion therapy.Ther Apher Dial. 2025 Aug;29(4):543-556. doi: 10.1111/1744-9987.70021. Epub 2025 Apr 15. Ther Apher Dial. 2025. PMID: 40234097 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous